JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances tantitumor function in a Fas/FasL signal-independent pathway

Overview of attention for article published in OncoTargets and therapy, July 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Hepatoid adenocarcinoma—Clinicopathological features and molecular characteristics

Article in Cancer Letters (March 2023)

Combination of CRAFITY score with Alpha-fetoprotein response predicts a favorable outcome of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.

Article in American Journal of Cancer Research (April 2022)

Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance

Article in Current Medicinal Chemistry (January 2021)